341205 Sigma-AldrichEtoposide - CAS 33419-42-0 - Calbiochem
Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.
More>> Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. Less<<Etoposide - CAS 33419-42-0 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: VP-16
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
33419-42-0 | C₂₉H₃₂O₁₃ |
Products
产品目录编号 | 包装 | 数量 / 包装 | |
---|---|---|---|
341205-25MGCN | 塑胶安瓿;塑胶针药瓶 | 25 mg |
Product Information | |
---|---|
CAS number | 33419-42-0 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₂₉H₃₂O₁₃ |
Chemical formula | C₂₉H₃₂O₁₃ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications | |
---|---|
Application | Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. |
Biological Information | |
---|---|
Primary Target | topoisomerase 2 |
Primary Target IC<sub>50</sub> | 59.2 µM inhibiting topoisomerase II |
Purity | >95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | KC0190000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
341205-25MGCN | 04055977215434 |
Documentation
Etoposide - CAS 33419-42-0 - Calbiochem MSDS
职位 |
---|
Etoposide - CAS 33419-42-0 - Calbiochem 分析证书
标题 | 批号 |
---|---|
341205 |
参考
参考信息概述 |
---|
De Lange, A.M., et al. 1995. J. Virol. 69, 2082. Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976. Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147. Terada, T., et al. 1993. J. Med. Chem. 36, 1689. Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70. Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451. Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73. |